STEPHANIE WHITBEY: Open Payments
NPI 1043796444 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 113 payments from 25 companies in 2025. Trend: 2023 $2,561 · 2024 $2,438 · 2025 $2,504
Food & beverage: $2,441Education: $63
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $587 |
| GENZYME CORPORATION | 13 | $329 |
| Regeneron Healthcare Solutions, Inc. | 9 | $231 |
| Viatris Specialty LLC | 5 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $196 |
| GlaxoSmithKline, LLC. | 11 | $187 |
| Grifols USA, LLC | 9 | $142 |
| United Therapeutics Corporation | 5 | $103 |
| Insmed, Inc. | 4 | $90 |
| JAZZ PHARMACEUTICALS INC. | 4 | $66 |
Products named: DUPIXENT, YUPELRI, FASENRA, TEZSPIRE, NUCALA, BREZTRI, Prolastin-C Liquid, Tyvaso.
Industry payments across MO — which companies pay providers there.
